Colgate Palmolive CO CL
We take great care to ensure that the data presented and summarized in this overview for COLGATE PALMOLIVE CO is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CL
View all-
Vanguard Group Inc Valley Forge, PA80.7MShares$7.42 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY61.6MShares$5.66 Billion0.14% of portfolio
-
State Street Corp Boston, MA48.4MShares$4.45 Billion0.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD30.9MShares$2.84 Billion0.37% of portfolio
-
Geode Capital Management, LLC Boston, MA20.2MShares$1.86 Billion0.17% of portfolio
-
Morgan Stanley New York, NY18.3MShares$1.68 Billion0.14% of portfolio
-
Wellington Management Group LLP Boston, MA15.2MShares$1.4 Billion0.28% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.53MShares$876 Million0.31% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL9.34MShares$858 Million1.52% of portfolio
-
First Eagle Investment Management, LLC8.89MShares$817 Million1.92% of portfolio
Latest Institutional Activity in CL
Top Purchases
Top Sells
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Insider Transactions at CL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 03
2024
|
Jennifer Daniels CLO and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
168
-0.27%
|
$15,792
$94.61 P/Share
|
Dec 03
2024
|
Gregory Malcolm EVP and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.51%
|
$3,948
$94.61 P/Share
|
Dec 03
2024
|
Prabha Parameswaran Grp Pres, Growth & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-2.57%
|
$21,526
$94.61 P/Share
|
Dec 03
2024
|
Noel R. Wallace Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
954
-0.35%
|
$89,676
$94.61 P/Share
|
Dec 03
2024
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.69%
|
$23,688
$94.61 P/Share
|
Dec 03
2024
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
SELL
Payment of exercise price or tax liability
|
Direct |
168
-2.31%
|
$15,792
$94.61 P/Share
|
Nov 27
2024
|
Gregory Malcolm EVP and Controller |
SELL
Bona fide gift
|
Direct |
1,387
-14.42%
|
-
|
Nov 26
2024
|
Gregory Malcolm EVP and Controller |
SELL
Open market or private sale
|
Direct |
1,054
-9.87%
|
$100,130
$95.94 P/Share
|
Nov 22
2024
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
33,333
-10.96%
|
$3,166,635
$95.0 P/Share
|
Nov 05
2024
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
45,410
-55.29%
|
$4,268,540
$94.11 P/Share
|
Nov 05
2024
|
Stanley J Sutula Iii Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,410
+35.6%
|
$3,496,570
$77.04 P/Share
|
Nov 04
2024
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
SELL
Open market or private sale
|
Indirect |
20,032
-28.95%
|
$1,862,976
$93.3 P/Share
|
Nov 01
2024
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-57.65%
|
$4,650,000
$93.53 P/Share
|
Nov 01
2024
|
Stanley J Sutula Iii Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+36.57%
|
$3,850,000
$77.04 P/Share
|
Oct 01
2024
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+0.7%
|
$26,145
$105.24 P/Share
|
Oct 01
2024
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
201
+0.61%
|
$21,105
$105.24 P/Share
|
Oct 01
2024
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+0.63%
|
$9,345
$105.24 P/Share
|
Oct 01
2024
|
Brian Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
178
+7.54%
|
$18,690
$105.24 P/Share
|
Sep 13
2024
|
Prabha Parameswaran Grp Pres, Growth & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-8.42%
|
$85,680
$105.73 P/Share
|
Sep 13
2024
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,143
-3.02%
|
$120,015
$105.73 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 176K shares |
---|---|
Exercise of conversion of derivative security | 578K shares |
Open market or private sale | 683K shares |
---|---|
Payment of exercise price or tax liability | 38.6K shares |
Discretionary transaction | 836 shares |
Bona fide gift | 1.39K shares |